Clinical Trials Sponsored by Cordis Corporation

Total 9091 results

Cordis Corporation

Completed

The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity. (DISCOVER)

Coronary Artery Disease

Germany
Cordis Corporation

Completed

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. (DOMINO)

Coronary Artery Disease

United Kingdom
Cordis Corporation

Completed

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment. (GREAT)

Renal Artery Stenosis

France, Germany, Netherlands
Cordis Corporation

Completed

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. (TROPICAL)

Coronary Artery Disease

Belgium, Germany
Cordis Corporation

Completed

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. (BIFURCATION)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

Coronary Artery Disease
Cordis Corporation

Completed

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent

Coronary Artery Disease

France
Cordis Corporation

Completed

Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)

Coronary Artery Disease

Brazil
Cordis Corporation

Completed

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

Coronary Artery Disease

France
Cordis Corporation
NAMSA

Completed

Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal)

Venous Vascular Closure

United States
Cordis Corporation
Conor Medsystems

Completed

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Coronary Disease

United States
Cordis Corporation
NAMSA; Qserve

Completed

Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY)

Peripheral Arterial Disease

France, Switzerland, Italy, Austria, Belgium, Spain
Cordis Corporation
Conor Medsystems

Completed

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Coronary Disease

United Kingdom
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions (NEVO RES-II)

Coronary Disease

Germany, Latvia
Cordis Corporation
Ensure Medical

Completed

Plug Arterial Closure System (PACS, 7F) (PACS 7F)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Mexico
Asklepios proresearch
Cordis Corporation

Completed

Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration

Left Ventricular Dysfunction

Germany
Cordis Corporation
Cardinal Health

Completed

Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)

Endovascular

China
Cordis Corporation
Conor Medsystems

Completed

The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)

Treatment of Symptomatic Ischemic Heart Disease

Italy
R&D Cardiologie
Cordis Corporation

Completed

Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium
R&D Cardiologie
Cordis Corporation

Completed

Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands
Wonju Severance Christian Hospital
Cordis Corporation

Terminated

Biofreedom Prospective Multicenter Observational Registry

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease Aggravated

Korea, Republic of
Aarhus University Hospital Skejby
Cordis Corporation

Completed

Nordic Bifurcation Stent Technique Study (BIF II) (BIF II)

Coronary Artery Disease

Denmark
Cordis Corporation
Quintiles, Inc.; HealthCore-NERI

Completed

A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION) (INSPIRATION)

Abdominal Aortic Aneurysm

United States, Japan
Sunil Rao
Cordis Corporation

Completed

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Coronary Occlusions

United States, Canada
Orqis Medical Corporation

Terminated

Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation

Heart Failure, Congestive

United States
Shin Yukuhashi Hospital
Abbott Medical Devices; Cordis Corporation

Unknown

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion (J-REVERSE)

Ischemic Heart Disease

Japan
Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Seung-Jung Park
Cordis Corporation; CardioVascular Research Foundation, Korea

Terminated

Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients (ZEST-AMI)

Myocardial Infarction

Korea, Republic of
Aarhus University Hospital Skejby
Abbott Medical Devices; Cordis Corporation

Completed

Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial (CLOSE-UP II)

Coronary Disease

Denmark
Cordis Corporation
FCRE (Foundation for Cardiovascular Research and Education)

Completed

PMCF Study for Cardiology Access Procedures

Coronary Artery Disease

Austria, Belgium
Cordis Corporation
FCRE (Foundation for Cardiovascular Research and Education)

Completed

PMCF Study for Peripheral Arteries Below the Knee (BTK)

Peripheral Artery Disease

Austria, Germany
Cordis Corporation
FCRE (Foundation for Cardiovascular Research and Education)

Completed

PMCF Study for Peripheral Arteries Above the Knee (ATK)

Peripheral Arterial Disease | Femoropopliteal Stenosis | Angiopathy, Peripheral

Austria, Netherlands, France
Spanish Society of Cardiology
Sanofi; Fondo de Investigacion Sanitaria; Boston Scientific Corporation; Medtronic and other collaborators

Terminated

Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients (TRIANA)

Acute Myocardial Infarction

Spain
Cordis Corporation
Massachusetts General Hospital; Prairie Education and Research Cooperative

Completed

Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN)

Cardiovascular Diseases | Peripheral Vascular Disease | Peripheral Artery Disease | Vascular Disease | PAD

United States, Belgium
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Olivier F. Bertrand
Eli Lilly and Company; Cordis Corporation

Completed

A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI (EASY-RESCUE)

Myocardial Infarction | Ischemia

Canada
Laval University
Eli Lilly and Company; Cordis Corporation; Quebec Heart Institute

Completed

A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI (EASY-MI)

Myocardial Infarction | Ischemia

Canada
Jordi Villalba Modol

Unknown

An Observational, Prospective Study of Patients With Chondral and/or Osteochondral Defects of the Knee Treated With NAMIC (KNAMIC)

Chondral Defect | Osteochondral Defect

Spain
Chris Hani Baragwanath Academic Hospital
Masimo Corporation

Completed

Usefulness of Non-invasive Pulse Co-oximetry Haemaglobin Measurements in Critically Ill Black Patients

Critically Ill Black Patients

South Africa
Association Pour le Développement des Soins Cardiologiques...
Boston Scientific Corporation; Medtronic; Abbott; Cordis Corporation

Completed

VerifyNow French Registry (VERIFRENCHY)

Bleeding | Aspirin | Stent Thrombosis | Angioplasty | Clopidogrel

France
Bavarian Nordic
National Cancer Institute (NCI); Therion Biologics Corporation

Completed

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Prostate Cancer

United States
Cordio Medical

Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM (DETECT-HF)

Heart Failure

United States, Israel
Cordio Medical

Recruiting

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

Chronic Heart Failure

United States, Israel
Cordio Medical

Completed

Remote Speech Analysis in HF Patients Undergoing Haemodialysis

Heart Failure

Israel
Cordio Medical

Completed

Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients

Coronavirus Infection

Israel
Cordio Medical

Completed

Clinical Evaluation of Cordio App in Adult ADHF Patients

Congestive Heart Failure

Israel
Cordio Medical

Recruiting

COMMUNITY STUDY- A Study to Collect Information for the Cordio System

Heart Failure

Israel
Charite University, Berlin, Germany
Boston Scientific Corporation; IKKF GmbH; IHF Ludwigshafen; Cordis Medizinische...

Completed

Economic Evaluation German Drug-Eluting Stent Registry

Coronary Heart Disease

Clinical Trials Sponsored by Cordis Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations